Investor at BoxGroup
Check size: BoxGroup publicly invests up to $1M. Third-party profiles estimate Disha's range at $500K–$1M, but no primary source confirms a personal range, so the firm ceiling is the safer planning assumption.
Disha invests at the earliest stages with a differentiated mix of finance, neuroscience, biotech R&D, and prior growth-investing exposure. Her public investor profile points to AI, enterprise infrastructure and software, digital and consumer health, biotech, and commerce. Within BoxGroup's generalist model, the through-line is an exceptional founder using technical or domain insight to create a category, not a rigid sector checklist.
Open with the non-obvious technical or customer insight and why this team is equipped to act on it. For AI, show evals, proprietary workflow or data advantage, and user outcomes; for health or biotech, cover evidence quality, regulatory and reimbursement paths, development milestones, and commercialization. Keep the story formation-stage honest and make the next de-risking milestone explicit.
Technically or scientifically credible founders, authentic founder-market fit, ambitious visions, strong product velocity, and a sharp insight about a customer or system that incumbents miss. Her cross-disciplinary background is particularly relevant when technical depth must translate into a usable product.
No personal pass list is public. Likely weaker fits include science without a product or commercialization path, AI without defensibility or measurable workflow benefit, teams without domain credibility, and later-stage raises outside BoxGroup's formation-stage focus.
Evaluate both technical validity and the path from a scientific advantage to a product users adopt, including regulatory, operational, and distribution constraints.
Test whether an AI product improves a complete customer workflow with measurable accuracy, speed, or cost—not simply whether it demonstrates model capability.
+ 3 more investments. View fund →